PortfoliosLab logoPortfoliosLab logo
ZTS vs. AMGN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZTS vs. AMGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zoetis Inc. (ZTS) and Amgen Inc. (AMGN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZTS achieves a -36.21% return, which is significantly lower than AMGN's 10.10% return. Over the past 10 years, ZTS has underperformed AMGN with an annualized return of 6.24%, while AMGN has yielded a comparatively higher 12.08% annualized return.


ZTS

1D
-2.25%
1M
7.21%
YTD
-36.21%
6M
-32.36%
1Y
-50.83%
3Y*
-20.79%
5Y*
-14.41%
10Y*
6.24%

AMGN

1D
0.32%
1M
8.85%
YTD
10.10%
6M
13.41%
1Y
23.93%
3Y*
20.61%
5Y*
11.36%
10Y*
12.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZTS vs. AMGN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZTS
Zoetis Inc.
-36.21%-21.75%-16.63%35.91%-39.51%48.26%25.76%55.71%19.45%35.55%
AMGN
Amgen Inc.
10.10%29.67%-6.77%13.46%20.43%0.87%-1.99%27.60%15.23%22.27%

Correlation

The correlation between ZTS and AMGN is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.38

Correlation (3Y)
Calculated over the trailing 3-year period

0.37

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (10Y)
Calculated over the trailing 10-year period

0.39

Correlation (All Time)
Calculated using the full available price history since Feb 1, 2013

0.41

Fundamentals

Market Cap

ZTS:

$33.61B

AMGN:

$193.23B

EPS

ZTS:

$6.04

AMGN:

$14.38

PE Ratio

ZTS:

13.17

AMGN:

24.70

PEG Ratio

ZTS:

1.48

AMGN:

1.42

PS Ratio

ZTS:

3.66

AMGN:

5.17

PB Ratio

ZTS:

10.40

AMGN:

21.03

Total Revenue (TTM)

ZTS:

$9.51B

AMGN:

$37.24B

Gross Profit (TTM)

ZTS:

$6.73B

AMGN:

$26.61B

EBITDA (TTM)

ZTS:

$3.95B

AMGN:

$17.27B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZTS vs. AMGN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZTS
ZTS Risk / Return Rank: 22
Overall Rank
ZTS Sharpe Ratio Rank: 11
Sharpe Ratio Rank
ZTS Sortino Ratio Rank: 22
Sortino Ratio Rank
ZTS Omega Ratio Rank: 11
Omega Ratio Rank
ZTS Calmar Ratio Rank: 33
Calmar Ratio Rank
ZTS Martin Ratio Rank: 11
Martin Ratio Rank

AMGN
AMGN Risk / Return Rank: 6868
Overall Rank
AMGN Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
AMGN Sortino Ratio Rank: 6666
Sortino Ratio Rank
AMGN Omega Ratio Rank: 6464
Omega Ratio Rank
AMGN Calmar Ratio Rank: 7070
Calmar Ratio Rank
AMGN Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZTS vs. AMGN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zoetis Inc. (ZTS) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZTSAMGNDifference
Sharpe ratioReturn per unit of total volatility

-2.30

Sortino ratioReturn per unit of downside risk

-3.52

Omega ratioGain probability vs. loss probability

0.66

1.17

-0.51

Calmar ratioReturn relative to maximum drawdown

-0.97

1.40

-2.36

Martin ratioReturn relative to average drawdown

-2.09

3.22

-5.31

ZTS vs. AMGN - Sharpe Ratio Comparison

The current ZTS Sharpe Ratio is -1.46, which is lower than the AMGN Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of ZTS and AMGN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZTS vs. AMGN - Drawdown Comparison

The maximum ZTS drawdown since its inception was -68.48%, which is greater than AMGN's maximum drawdown of -63.48%. Use the drawdown chart below to compare losses from any high point for ZTS and AMGN.


Loading charts...

Drawdown Indicators


ZTSAMGNDifference

Max Drawdown

Largest peak-to-trough decline

-68.48%

-63.48%

-5.00%

Max Drawdown (1Y)

Largest decline over 1 year

-54.15%

-16.57%

-37.58%

Max Drawdown (3Y)

Largest decline over 3 years

-61.77%

-22.74%

-39.03%

Max Drawdown (5Y)

Largest decline over 5 years

-68.48%

-24.86%

-43.62%

Max Drawdown (10Y)

Largest decline over 10 years

-68.48%

-24.86%

-43.62%

Current Drawdown

Current decline from peak

-66.20%

-7.80%

-58.40%

Average Drawdown

Average peak-to-trough decline

-14.85%

-16.77%

+1.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.53%

7.19%

+19.34%

Volatility

ZTS vs. AMGN - Volatility Comparison

Zoetis Inc. (ZTS) has a higher volatility of 8.65% compared to Amgen Inc. (AMGN) at 7.92%. This indicates that ZTS's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZTSAMGNDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.65%

7.92%

+0.73%

Volatility (6M)

Calculated over the trailing 6-month period

31.45%

19.22%

+12.23%

Volatility (1Y)

Calculated over the trailing 1-year period

35.73%

27.79%

+7.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.77%

23.97%

+4.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.10%

24.86%

+2.24%

Dividends

ZTS vs. AMGN - Dividend Comparison

ZTS's dividend yield for the trailing twelve months is around 2.59%, less than AMGN's 2.76% yield.


PositionTTM20252024202320222021202020192018201720162015
AMGN
Amgen Inc.
2.76%2.91%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%
ZTS
Zoetis Inc.
2.59%1.59%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%

Financials

ZTS vs. AMGN - Financials Comparison

This section allows you to compare key financial metrics between Zoetis Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B20222023202420252026
2.26B
8.62B
(ZTS) Total Revenue
(AMGN) Total Revenue
Values in USD except per share items

ZTS vs. AMGN - Profitability Comparison

The chart below illustrates the profitability comparison between Zoetis Inc. and Amgen Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20222023202420252026
71.7%
68.2%
Portfolio components
ZTS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported a gross profit of 1.62B and revenue of 2.26B. Therefore, the gross margin over that period was 71.7%.

AMGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported a gross profit of 5.87B and revenue of 8.62B. Therefore, the gross margin over that period was 68.2%.

ZTS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported an operating income of 853.00M and revenue of 2.26B, resulting in an operating margin of 37.7%.

AMGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported an operating income of 2.67B and revenue of 8.62B, resulting in an operating margin of 30.9%.

ZTS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported a net income of 601.00M and revenue of 2.26B, resulting in a net margin of 26.6%.

AMGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported a net income of 1.82B and revenue of 8.62B, resulting in a net margin of 21.1%.


Frequently Asked Questions


ZTS and AMGN have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZTS has higher volatility (8.65%) compared to AMGN (7.92%). In terms of maximum drawdown, ZTS dropped -68.48% vs AMGN's -63.48%.

AMGN currently has the higher Sharpe Ratio (0.84 vs -1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZTS and AMGN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer